VGEN

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 949 Fell Street
  • Baltimore, MD 21231

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2015 10-Q
CIK 0001453001
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: MD, USA
Year of Inc. 2007
Employees 20 a/o Jun 07, 2016
Company Officers/Contacts
Peter Morsing COO
Eric Smith Legal Counsel
Earl Miller Finance Director, Asst. Treasurer
Company Directors
Michael G. Hanna Chairman Emeritus
Haka Edstrom
Michael Hagerman
Anders Hallidin
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
945 E Park Drive
Suite 103
Harrisburg, PA, 17111
United States
 
Securities Counsel
Venable LLP
750 East Pratt Street
Suite 900
Baltimore, MD, 21202
United States
 
Investor Relations Firm
VGEN Security Details
Share Structure
Market Value1 $5,660,406 a/o Mar 24, 2017
Authorized Shares 200,000,000 a/o Apr 14, 2015
Outstanding Shares 37,736,041 a/o May 26, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 10,001,329 a/o May 23, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
Globex Transfer, LLC
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Jan 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security